Crossmark

Comparative policy analysis of national rare disease funding policies in Australia, Singapore, South Korea, the United Kingdom and the United States: a scoping review

Crossref DOI link: https://doi.org/10.1186/s13561-024-00519-1

Published Online: 2024-06-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ng, Qin Xiang

Ong, Clarence

Chan, Kai En

Ong, Timothy Sheng Khai

Lim, Isabelle Jia Xuan

Tang, Ansel Shao Pin

Chan, Hwei Wuen

Koh, Gerald Choon Huat
License Information

Text and Data Mining valid from 2024-06-19

Version of Record valid from 2024-06-19
More Information

Article History

Received: 22 March 2024

Accepted: 12 June 2024

First Online: 19 June 2024

Declarations

:

: Not applicable. No patients or participants were directly involved in this study as it was a review of published literature.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below